Experienced in Neonatal Onset Multisystem Inflammatory Disease

Fabrizio De Benedetti

Rome, IT 
Experienced in Neonatal Onset Multisystem Inflammatory Disease
Rome, IT 
OverviewLocationsClinical Research

Overview

Fabrizio De Benedetti practices in Rome, Italy. Mr. De Benedetti is rated as an Experienced expert by MediFind in the treatment of Neonatal Onset Multisystem Inflammatory Disease. His top areas of expertise are Juvenile Idiopathic Arthritis (JIA), Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

His clinical research consists of co-authoring 201 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Neonatal Onset Multisystem Inflammatory Disease.

Gender
Male

Locations

Rome, Italy
Other Locations
Brescia, Italy
Turin, Italy
Pavia, Italy
Gesu, Italy
Rimini, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Three-period Multicenter Study, With a Randomized-withdrawal, Double-blind, Placebo-controlled Design to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
A Three-period Multicenter Study, With a Randomized-withdrawal, Double-blind, Placebo-controlled Design to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2025
Intervention Type: Biological
Study Drug: MAS825
Study Phase: Phase 2
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Pilot, Open-label, Single Arm, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)
A Pilot, Open-label, Single Arm, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)
Enrollment Status: Completed
Publish Date: May 17, 2022
Intervention Type: Drug
Study Drug: Emapalumab Anti-IFN-Gamma Antibody
Study Phase: Phase 2
View 2 Less Clinical Trials

201 Total Publications

Genome-wide DNA methylation analysis identifies kidney epigenetic dysregulation in a cystinosis mouse model.
Genome-wide DNA methylation analysis identifies kidney epigenetic dysregulation in a cystinosis mouse model.
Journal: Frontiers in cell and developmental biology
Published: June 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Benedetti's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 12 Advanced Conditions
View All 53 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile